Annovis Bio, Inc. (NYSE:ANVS) Receives $34.75 Average Price Target from Analysts
Shares of Annovis Bio, Inc. (NYSE:ANVS – Get Free Report) have received an average rating of “Buy” from the six research firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy […]
Shares of Annovis Bio, Inc. (NYSE:ANVS – Get Free Report) have received an average rating of “Buy” from the six research firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy […]
